NCT00168038 - Treatment of Chronic Immune Thrombocytopenic Purpura (ITP) With Intravenous Immunoglobulin IgPro10 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2004

Study Completion Date

February 28, 2006

Conditions

Immune Thrombocytopenic Purpura

Interventions

BIOLOGICAL

Immunoglobulin Intravenous (Human)

A dose of 1 g IgG per kg body weight (bw) administered on two consecutive days resulting in the total treatment dosage of 2 g IgG per kg bw.

Trial Locations (17)

Study Site, Berlin

Study Site, Rome

Study Site, Bialystok

Study Site, Gdansk

Study Site, Lodz

Study Site, Poznan

Study Site, Warsaw

Study Site, Wroclaw

Study Site, Moscow

Study Site (19), Saint Petersburg

Study Site (20), Saint Petersburg

Study Site (21), Saint Petersburg

Study Site, Dnipropetrovsk

Study Site (02), Kyiv

Study Site (03), Kyiv

Study Site, Lviv

Study Site, Taunton